Related Experiment Video
Updated: Aug 6, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
How does diabetes alter treatment in the dental office?
1USAF Hospital, Eglin Air Force Base, Florida, USA.
Journal (Indiana Dental Association)
|February 7, 2001
Summary
Dental patients with diabetes face increased hypoglycemia risk due to intensive treatments. Dental professionals must know how to prevent and manage these emergencies during appointments.
Area of Science:
- Medicine
- Dentistry
- Endocrinology
Background:
- Diabetes mellitus impacts 7% of Americans, making diabetic patients common in dental practices.
- Modern diabetes management intensifies treatment, reducing long-term complications but potentially increasing acute risks.
Purpose of the Study:
- To inform dental practitioners about the heightened risk of hypoglycemic emergencies in diabetic patients undergoing intensive treatment.
- To outline essential knowledge for preventing, recognizing, and managing hypoglycemia in a dental setting.
Main Methods:
- Review of current medical management of diabetes mellitus.
- Analysis of the relationship between intensified diabetes treatment and emergency risks.
- Identification of key clinical considerations for dental professionals.
Main Results:
- Intensified diabetes treatment regimens correlate with a higher incidence of hypoglycemic emergencies.
- Dental appointments can precipitate hypoglycemic events in susceptible patients.
- Proactive management and preparedness are crucial for patient safety.
Conclusions:
- Dental practitioners require specific knowledge regarding hypoglycemia prevention and management in diabetic patients.
- Understanding the risks associated with modern diabetes care is vital for safe dental practice.
- Prompt recognition and treatment of hypoglycemia can mitigate adverse outcomes.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...